Manta Biofuel
Out of BusinessManta Biofuel, Inc.
Energy & Cleantech · Owings Mills, MD · Founded 2018
Reinventing crude oil, renewably this time
Financials
FY2018–FY2022 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round. Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth, so don't compare them with the other bars.
Cap table
Share counts as of Dec 31, 2022| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common stock | 1,800,000 | — | 100.0% | $2.10Mar 2023 |
Sold to the crowd
- Reg CF · Nov 2020Crowd SAFE$1.9M· 4,083 investors
- Reg CF · Mar 2023196,021 shares at $2.10$411.6K· 505 investors
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
4 people
Capitalizing on his nearly 30 years of experience in the biotech industry, Chris leads Manta’s business operations and strategy. Over his extensive career, he’s held executive roles in both R&D and business leadership functions for start-ups and large multinational companies. Highlights of his career include 20 years with Martek Biosciences (Columbia, Maryland) and 7 years with DSM Nutritional Products (Kaiseraugst, Switzerland). During his tenure with both extremely successful organizations, he was able to bridge his background in R&D and experience in business to translate technology into commercial success. Chris holds a M.S. in Biotechnology from the Johns Hopkins University.
A seasoned entrepreneur with 20 years of biotechnology industry experience, Onur Unal has extensive experience with startups in product and business management capacities. He holds a BS in Genetics from UC Davis, and an M.S. in Pharmacology and an M.B.A. from Penn State University.
Ryan leads Manta’s technical development and brings a unique perspective to the development of algal biofuels. Rare among scientists, he has 15+ years of practical experience in large scale agriculture from working on his family’s 2000 acre grain farm. This pragmatic problem solving mentality is backed by a deep knowledge of the field of algal biofuels which was the focus of his Ph.D. research. Since founding Manta, he has led his team through the successful completion of more than ten peer-reviewed awards that the company has received. Ryan holds a Ph.D. in algal biofuels from the University of Maryland, and is the inventor of the company’s magnetic algae harvesting technology and low cost continuous flow hydrothermal liquefaction system.
Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 2 of 6 annual reports (FY2020–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 13 filings on EDGAR- Form C-TRMar 11, 20240001826436-24-000001EDGAR
- Form C-UOct 2, 20230001665160-23-001805EDGAR
- Form C/AAug 22, 20230001665160-23-001679EDGAR
- Form C/AJun 30, 20230001665160-23-001465EDGAR
- Form C/AApr 27, 20230001665160-23-000931EDGAR
- Form C-ARApr 26, 20230001821386-23-000003EDGAR
- Form CMar 10, 20230001665160-23-000392EDGAR
- Form C-ARApr 27, 20220001831877-22-000002EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.